Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
therapeutic estradiol
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Hormone Replacement Therapy in Menopausal or Perimenopausal Women With Prior Stage 0-II Breast Cancer
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Closed
Age:
Not specified
Sponsor:
Other
Protocol IDs:
ROC-HABITS
, EORTC-10992, IBCSG-17-98, SBG-HABITS, EU-98077, NCT00003771
2.
Phase II Pilot Endocrine Therapy with Sequential TMX and Estradiol plus Chemotherapy with High-Dose MTX/5-FU with Leucovorin Rescue in Patients with Metastatic Carcinoma of the Breast
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
under 75
Sponsor:
Protocol IDs:
NCOG-P-1B832
, NCOG-P-1B-83-2
3.
Phase II Combined Modality Therapy with Hormonal Therapy Using Estradiol, Chemotherapy with FUVAC (5-FU/VBL/ADR/CTX) or FAC (5-FU/ADR/CTX), Radiotherapy, and Surgery in Patients with Advanced Stage III Breast Cancer (Summary Last Modified 09/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-8568
4.
Phase II Study of Chemohormonal Therapy with ESDL/ZDX/VBL/DOX/TSPA in Patients with Metastatic Breast Cancer (Summary Last Modified 01/92)
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 to physiologic 70
Sponsor:
NCI
Protocol IDs:
MSKCC-90094
, NCI-T89-0232C, T89-0232
5.
Phase II Study of Transdermal Estradiol (Climara®) in Patients With Hormone- and Chemotherapy-Refractory Metastatic Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
CINJ-080419-5247
, NJ 1805, CINJ-5155V2, NCT00255632, CINJ-NJ1805
6.
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
05-5564-V 01
, NCT00167648
7.
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
04-0412
, NCT00324259
8.
Phase II Study of Paclitaxel Poliglumex and Transdermal Estradiol in Patients With Androgen-Independent Stage IV Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
OHSU-2656
, SOL-06048-L, NCT00459810
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute